SCHEMBL480197

SCHEMBL480197

[CH2]C(C)(CCCO)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 2/20 0.38
CYP4A11 Q02928 2/20 0.38
ARG2 P78540 2/20 0.37
FFAR1 O14842 2/20 0.37
GPR84 Q9NQS5 1/20 0.37
FFAR4 Q5NUL3 1/20 0.37
CAMK2A Q9UQM7 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
TSHR P16473 2/20 0.33
ALDH1A1 P00352 2/20 0.33
PPARA Q07869 1/20 0.33
ACLY P53396 1/20 0.33
CPT2 P23786 1/20 0.33
ACACB O00763 1/20 0.32
ACACA Q13085 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
HIF1A Q16665 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
ARG1 P05089 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pivalate SCHEMBL6905029 0.76 GPR84 (0.46) CYP4F2CYP4A11ARG2FFAR1GPR84
SCHEMBL181323 0.75 TSHR (0.46) CYP4F2CYP4A11ARG2FFAR1GPR84
SCHEMBL28133882 0.75 CYP4F2 (0.41) CYP4F2CYP4A11ARG2FFAR1GPR84
SCHEMBL2919376 0.75 TSHR (0.43) CYP4F2CYP4A11ARG2FFAR1GPR84
SCHEMBL13504567 0.75 TSHR (0.43) CYP4F2CYP4A11ARG2FFAR1GPR84
SCHEMBL5948432 0.75 TSHR (0.43) CYP4F2CYP4A11ARG2FFAR1GPR84
SCHEMBL5075315 0.75 ACLY (0.56) CYP4F2CYP4A11ARG2FFAR1GPR84
SCHEMBL5855982 0.74
Pivalate SCHEMBL29150541 0.74 FFAR1 (0.50) CYP4F2CYP4A11ARG2FFAR1GPR84
SCHEMBL9837397 0.73 ACLY (0.54) CYP4F2CYP4A11ARG2FFAR1GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7670627-B2 pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients SALVONA IP LLC (US) 2010-03-02 US claimed
EP-1720522-A1 ORAL CONTROLLED RELEASE SYSTEM FOR TARGETED DRUG DELIVERY INTO THE CELL AND ITS NUCLEUS FOR GENE THERAPY, DNA VACCINATION AND ADMINISTRATION OF GENE BASED DRUGS Salvona LLC (US) 2006-11-15 EP claimed
WO-2005084644-A1 ORAL CONTROLLED RELEASE SYSTEM FOR TARGETED DRUG DELIVERY INTO THE CELL AND ITS NUCLEUS FOR GENE THERAPY, DNA VACCINATION AND ADMINISTRATION OF GENE BASED DRUGS SALVONA LLC (US) 2005-09-15 WO claimed
EP-1569619-A1 PH TRIGGERED TARGETED CONTROLLED RELEASE SYSTEMS Salvona LLC (US) 2005-09-07 EP claimed
EP-1553926-A2 SURFACE DISSOLUTION AND/OR BULK EROSION CONTROLLED RELEASE COMPOSITIONS AND DEVICES Salvona LLC (US) 2005-07-20 EP claimed
US-20040234597-A1 pH triggered site specific targeted controlled drug delivery system for the treatment of cancer SHEFER ADI (US) 2004-11-25 US claimed
US-20040224019-A1 Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination, and administration of gene based drugs SALVONA-IP LLC 2004-11-11 US claimed
WO-2004052339-A1 PH TRIGGERED TARGETED CONTROLLED RELEASE SYSTEMS SALVONA LLC (US) 2004-06-24 WO claimed
US-20040109894-A1 PH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients SALVONA L.L.C. 2004-06-10 US claimed
WO-2004043513-A2 SURFACE DISSOLUTION AND/OR BULK EROSION CONTROLLED RELEASE COMPOSITIONS AND DEVICES SALVONA LLC (US) 2004-05-27 WO claimed
US-20040062778-A1 Surface dissolution and/or bulk erosion controlled release compositions and devices SHEFER ADI (US) 2004-04-01 US claimed
EP-3851166-B1 STABLE DISPERSIONS SYMRISE AG (DE) 2024-05-29 EP disclosed
CN-115591545-B Preparation method and catalytic application of osmium-based solid solution material 西安交通大学 2024-01-26 CN disclosed
CN-115591545-A Preparation method and catalytic application of osmium-based solid solution material 西安交通大学(CN) 2023-01-13 CN disclosed
CN-115414947-A Preparation method of diatomic site catalyst and application of catalyst in carbon dioxide methanation 陕西天易元素科技有限公司 2022-12-02 CN disclosed
US-20030152629-A1 Multi component controlled release system for oral care, food products, nutracetical, and beverages SHEFER ADI (US) 2003-08-14 US disclosed
EP-0539025-B1 Fragrance microcapsules for fabric conditioning UNILEVER PLC (GB) 1998-12-16 EP disclosed
US-5425887-A Hydrocarbon based quaternary ammonium salt as fabric conditioner and capsule consists of emulsion of perfume and solution of water soluble natural or synthetic polymer and water LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) 1995-06-20 US disclosed
US-5246603-A Wax and fragrance oil emulsion LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) 1993-09-21 US disclosed
EP-0539025-A2 Fragrance microcapsules for fabric conditioning UNILEVER PLC (GB) 1993-04-28 EP disclosed